Kyverna Therapeutics, Inc.
KYTX
$7.66
-$0.19-2.42%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.33% | 63.17% | -19.15% | -12.76% | -15.15% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -29.04% | 92.76% | 42.91% | -47.02% | 8.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -- | -- | -- | -- |
| Total Current Assets | -14.57% | 61.76% | -18.38% | -13.46% | -14.78% |
|
|
|||||
| Total Current Assets | -14.57% | 61.76% | -18.38% | -13.46% | -14.78% |
| Net Property, Plant & Equipment | 79.61% | -14.28% | -16.56% | -13.93% | -17.39% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.04% | -7.70% | 28.34% | 9.59% | 24.00% |
| Total Assets | -12.53% | 57.00% | -17.37% | -13.10% | -14.44% |
|
|
|||||
| Total Accounts Payable | 118.68% | 75.93% | -69.59% | 17.06% | 83.22% |
| Total Accrued Expenses | -40.89% | 0.15% | 3.32% | 23.83% | -15.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -49.99% | 7.71% | 3.05% | -0.25% | -9.01% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -18.67% | 7.72% | -14.87% | 19.52% | -1.37% |
|
|
|||||
| Total Current Liabilities | -18.67% | 7.72% | -14.87% | 19.52% | -1.37% |
| Long-Term Debt | 0.28% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2,074.38% | -76.10% | -42.83% | -30.15% | -22.06% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -0.17% | 74.81% | -16.43% | 14.97% | -3.71% |
|
|
|||||
| Common Stock & APIC | 0.49% | 21.91% | 0.81% | 0.46% | 0.41% |
| Retained Earnings | -9.35% | -9.77% | -10.50% | -13.66% | -16.94% |
| Treasury Stock & Other | -198.97% | 234.48% | 245.00% | -1,900.00% | -100.95% |
| Total Common Equity | -15.80% | 52.87% | -17.59% | -17.69% | -15.97% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.80% | 52.87% | -17.59% | -17.69% | -15.97% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.80% | 52.87% | -17.59% | -17.69% | -15.97% |
|
|
|||||